Latest news
Daily tablet shows promise as first treatment for Stargardt disease
Posted: Monday 2 December 2024
A new drug for Stargardt disease, called gildeuretinol (ALK-001), has received special recognition from the Food and Drug Administration in the US, highlighting its potential to treat the condition.
Find out more
First-of-a-kind study shines light on DMO treatment among diverse backgrounds
Posted: Friday 29 November 2024
For the first time, people from underrepresented ethnic and racial backgrounds were the focus of a clinical trial which reported improved vision after receiving treatment for diabetic macular oedema (DMO).
Find out more
Supplements offer hope for advanced AMD, says researcher
Posted: Monday 25 November 2024
Dr Tiarnan Keenan, a clinician scientist at the National Eye Institute in the US, shares groundbreaking insights into the benefits of AREDS2 supplements for people with geographic atrophy (GA), an advanced stage of dry age-related macular degeneration (AMD).
Find out more
First UK hearing and sight loss survey launched
Posted: Thursday 7 November 2024
The first survey in the UK to collect data on vision and hearing loss has been launched. The UK National Eye Health and Hearing Study, aims to record data to inform the NHS and policymakers and is a collaboration between sensory loss charities, Anglia Ruskin University, eye and hearing care professionals and the public sector.
Find out more
“Fundraising for research is a really integral part of what we should be doing”
Posted: Wednesday 23 October 2024
The Newmedica team swapped the clinic for the great outdoors, battling the dark, wind and rain in their efforts to raise vital funds for research to find a cure.
Find out more
Half of UK adults expect vision loss within a decade, yet many skipping eye tests
Posted: Thursday 17 October 2024
A recent survey of over 2,000 UK adults found that half of people expect to experience some form of sight loss within the next decade, yet more than a quarter do not have regular eye tests.
Find out more
World Sight Day: Myopia becoming a major global issue
Posted: Thursday 10 October 2024
Myopia, also known as short sightedness, is becoming a major global issue with new research showing one in three children is affected. In a recent My Macular and Me webinar Dr Annegret Dahlmann-Noor, called for increased awareness and research investment in MMD, which she called an "increasingly common problem."
Find out more
Home-monitoring app boosts patients' understanding of macular disease
Posted: Monday 29 July 2024
A recent study by OKKO Health has revealed significant improvements in health literacy among users of its home-monitoring app.
Find out more
AREDS2 supplements slow sight loss in late-stage dry AMD
Posted: Friday 19 July 2024
New research has found that taking a daily vitamin and mineral supplement can slow the progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD).
Find out more
Radiation treatment could reduce frequency of injections
Posted: Tuesday 2 July 2024
A new study led by researchers from King's College London and King's College Hospital NHS Foundation Trust has shown that radiation could significantly reduce the number of injections needed to treat wet age-related macular degeneration (AMD).
Find out more
"I know my eyesight will change, so I want to live in the here and now"
Posted: Monday 24 June 2024
Nancy assumed her vision changes were just part of getting older. When she noticed blank spots and disappearing words while reading, she thought she needed a new prescription.
Find out more
Stopping the build-up of toxic waste in dry AMD
Posted: Monday 24 June 2024
In dry age-related macular degeneration (AMD), toxic waste builds up in the retina because cells can't clear it. Dr. Arjuna Ratnayaka is researching ways to activate the cells’ waste removal system to reduce this buildup and protect vision.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter